Mark Bloomston

15.1k total citations · 2 hit papers
159 papers, 7.5k citations indexed

About

Mark Bloomston is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Bloomston has authored 159 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 78 papers in Surgery and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Bloomston's work include Pancreatic and Hepatic Oncology Research (51 papers), Gastric Cancer Management and Outcomes (28 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers). Mark Bloomston is often cited by papers focused on Pancreatic and Hepatic Oncology Research (51 papers), Gastric Cancer Management and Outcomes (28 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers). Mark Bloomston collaborates with scholars based in United States, Canada and Italy. Mark Bloomston's co-authors include Wendy L. Frankel, Alexander S. Rosemurgy, Carlo M. Croce, Emmanuel E. Zervos, E. Christopher Ellison, Tanios Bekaii‐Saab, Carl Schmidt, Peter Muscarella, Gregory B. Lesinski and Hansjüerg Alder and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Mark Bloomston

156 papers receiving 7.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis

2007 939 citations Mark Bloomston, Wendy L. Frankel et al. profile →
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

2016 401 citations Thomas A. Mace, Reena Shakya et al. Gut profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mark Bloomston	3.4k	2.6k	2.2k	2.1k	1.6k	159	7.5k
Tetsuo Ohta	3.7k 1.1×	3.0k 1.2×	1.9k 0.9×	1.1k 0.5×	1.9k 1.2×	338	7.3k
Suguru Yamada	4.0k 1.2×	2.8k 1.1×	1.9k 0.9×	1.2k 0.6×	2.4k 1.5×	293	7.4k
Tsutomu Fujii	5.2k 1.5×	3.4k 1.3×	2.2k 1.0×	1.4k 0.7×	2.9k 1.8×	330	8.7k
Sachio Fushida	2.7k 0.8×	2.7k 1.0×	2.3k 1.1×	1000 0.5×	2.7k 1.7×	313	7.5k
Aatur D. Singhi	3.9k 1.1×	2.3k 0.9×	1.7k 0.8×	1.3k 0.6×	1.1k 0.7×	225	6.8k
Robert R. McWilliams	5.9k 1.7×	1.9k 0.7×	2.4k 1.1×	1.9k 0.9×	1.9k 1.2×	206	8.4k
Mitsuro Kanda	2.8k 0.8×	2.2k 0.8×	1.5k 0.7×	972 0.5×	2.1k 1.3×	274	5.8k
Baki Topal	2.5k 0.7×	2.3k 0.9×	1.4k 0.7×	1.0k 0.5×	2.0k 1.2×	100	5.6k
Kazuo Shirouzu	4.2k 1.2×	3.8k 1.5×	2.0k 0.9×	786 0.4×	2.9k 1.8×	484	8.8k
Masahiko Koike	2.1k 0.6×	1.9k 0.7×	1.7k 0.8×	830 0.4×	1.9k 1.2×	234	5.4k

Countries citing papers authored by Mark Bloomston

Since Specialization

Citations

This map shows the geographic impact of Mark Bloomston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bloomston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bloomston more than expected).

Fields of papers citing papers by Mark Bloomston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bloomston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bloomston. The network helps show where Mark Bloomston may publish in the future.

Co-authorship network of co-authors of Mark Bloomston

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bloomston. A scholar is included among the top collaborators of Mark Bloomston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bloomston. Mark Bloomston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nichols, W. Garrett, et al.. (2023). 653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC). SHILAP Revista de lepidopterología. A744–A744. 1 indexed citations

Talbert, Erin E., Jennifer Yang, Thomas A. Mace, et al.. (2016). Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities. Molecular Cancer Therapeutics. 16(2). 344–356. 29 indexed citations

McMichael, Elizabeth L., Alena Cristina Jaime‐Ramirez, Kristan Guenterberg, et al.. (2016). IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells. Clinical Cancer Research. 23(2). 489–502. 55 indexed citations

Mace, Thomas A., Reena Shakya, Jason R. Pitarresi, et al.. (2016). IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut. 67(2). 320–332. 401 indexed citations breakdown →

Tran, Thuy B., David J. Worhunsky, Jeffrey A. Norton, et al.. (2015). Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative. Annals of Surgical Oncology. 22(S3). 840–847. 30 indexed citations

Zhang, Xuchen, Thomas D. Schiano, Swan N. Thung, et al.. (2013). Neuropathology. Laboratory Investigation. 93. 413–420. 1 indexed citations

Mace, Thomas A., Zeenath Ameen, Amy Collins, et al.. (2013). Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner. Cancer Research. 73(10). 3007–3018. 344 indexed citations

Shirley, Lawrence A., Laura K. Aguilar, Estuardo Aguilar-Córdova, Mark Bloomston, & Jon Walker. (2013). Therapeutic Endoscopic Ultrasonography: Intratumoral Injection for Pancreatic Adenocarcinoma. Gastroenterology Research and Practice. 2013. 1–3. 11 indexed citations

Henry, Jon C., Hooman Khabiri, G. Guy, et al.. (2012). Best radiological response to trans‐arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes. HPB. 15(3). 196–202. 8 indexed citations

10.

Fisher, Sarah B., Sameer H. Patel, David A. Kooby, et al.. (2012). Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB. 14(8). 514–522. 58 indexed citations

11.

Peng, Peter D., Omar Hyder, Mark Bloomston, et al.. (2012). Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies. HPB. 14(8). 523–531. 21 indexed citations

12.

Collins, Amy, Sylwia E. Wojcik, James Liu, et al.. (2012). Concomitant dysregulation of microRNAs miR‐151‐3p and miR‐126 correlates with improved survival in resected cholangiocarcinoma. HPB. 15(4). 260–264. 33 indexed citations

13.

Mundy-Bosse, Bethany L., Gregory Young, Todd M. Bauer, et al.. (2011). Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy. Cancer Immunology Immunotherapy. 60(9). 1269–1279. 108 indexed citations

14.

Hatzaras, Ioannis, Carl Schmidt, Peter Muscarella, et al.. (2010). Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB. 12(2). 134–138. 53 indexed citations

15.

Hatzaras, Ioannis, et al.. (2010). Predictors of Survival in Periampullary Cancers Following Pancreaticoduodenectomy. Annals of Surgical Oncology. 17(4). 991–997. 123 indexed citations

16.

Zhou, Xin, Wendy L. Frankel, Mark Bloomston, et al.. (2009). Neuropathology. Laboratory Investigation. 89. 327–335. 1 indexed citations

17.

Nau, Peter, W. Scott Melvin, Vimal K. Narula, et al.. (2009). Laparoscopic Distal Pancreatectomy with Splenic Conservation: An Operation without Increased Morbidity. Gastroenterology Research and Practice. 2009. 1–5. 26 indexed citations

18.

Ross, Sharona, Donald Thometz, Francesco M. Serafini, et al.. (2009). Renal haemodynamics and function following partial portal decompression. HPB. 11(3). 229–234. 3 indexed citations

19.

Bloomston, Mark, Atul Bhardwaj, E. Christopher Ellison, & Wendy L. Frankel. (2006). Epidermal Growth Factor Receptor Expression in Pancreatic Carcinoma Using Tissue Microarray Technique. Digestive Surgery. 23(1-2). 74–79. 94 indexed citations

20.

Rakita, Steven, Mark Bloomston, Christopher M. Chambers, et al.. (2005). Esophagography Predicts Favorable Outcomes after Laparoscopic Nissen Fundoplication for Patients with Esophageal Dysmotility. Journal of the American College of Surgeons. 201(3). 335–342. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact